Company: INMB
Filing Date: 2025-06-30
Form Type: 424B5
Source: 0001213900-25-059298
Chunk: 22

Company: Inmune Bio, Inc.
Filing Date: 2025-06-30
Form: 424B5
Chunk 22
---
 will contain information, where applicable, as to any other listing of
the securities on the NASDAQ Capital Market or any other securities market or exchange covered by the prospectus supplement. Prospective
purchasers of our securities are urged to obtain current information as to the market prices of our securities, where applicable.

We may offer the securities
directly or through agents or to or through underwriters or dealers. If any agents or underwriters are involved in the sale of the securities
their names, and any applicable purchase price, fee, commission or discount arrangement between or among them, will be set forth, or will
be calculable from the information set forth, in an accompanying prospectus supplement. We can sell the securities through agents, underwriters
or dealers only with delivery of a prospectus supplement describing the method and terms of the offering of such securities. See “Plan
of Distribution.”

The aggregate market value
of our outstanding common stock held by non-affiliates was approximately $238.5 million which was calculated based on 8,882,870 shares
of outstanding common stock held by non-affiliates as of March 9, 2021, and a price per share of $26.85, the closing price of our common
stock on January 19, 2021.

The securities offered by this prospectus involve a high degree of risk. See “Risk Factors” beginning on page 5, in addition to Risk Factors contained in the applicable prospectus supplement.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>This prospectus is dated May 5, 2021

Table of Contents</div>

|                                                           |     | Page |
| ABOUT THIS PROSPECTUS                                     |     |    1 |
| CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS |     |    2 |
| ABOUT INMUNE BIO                                          |     |    3 |
| RISK FACTORS                                              |     |    5 |
| USE OF PROCEEDS                                           |     |    6 |
| DESCRIPTION OF CAPITAL STOCK                              |     |    7 |
| DESCRIPTION OF WARRANTS                                   |     |    9 |
| DESCRIPTION OF UNITS                                      |     |   10 |
| PLAN OF DISTRIBUTION                                      |     |   10 |
| EXPERTS                                                   |     |